| November 16, 2011 |
AFEXA MAILS INFORMATION CIRCULAR IN CONNECTION WITH ITS PRIVATIZATION |
| October 27, 2011 |
VALEANT ANNOUNCES TAKE-UP OF ADDITIONAL AFEXA SHARES AND SPECIAL MEETING OF SHAREHOLDERS OF AFEXA TO APPROVE ITS PRIVATIZATION
|
| October 27, 2011 |
AFEXA ANNOUNCES ADDITIONAL TAKE-UP OF SHARES UNDER VALEANT OFFER AND SPECIAL MEETING OF SHAREHOLDERS TO APPROVE THE PRIVATIZATION OF AFEXA |
| October 18, 2011 |
VALEANT ANNOUNCES RESULTS OF FRIENDLY OFFER FOR AFEXA LIFE SCIENCES INC.
|
| October 18, 2011 |
News Release – AFEXA ANNOUNCES TAKE-UP OF SHARES UNDER VALEANT OFFER
|
| October 17, 2011 |
VALEANT - NOTICE OF EXTENSION
|
| October 3, 2011 |
NOTICE OF VARIATION
|
| October 3, 2011 |
Cover letter from Valeant mailed with Directors’ Circular
|
| October 3, 2011 |
Notice of Change mailed with Directors' circular
|
| October 3, 2011 |
Cover letter mailed with Directors' circular
|
| October 3, 2011 |
Paladin Labs Advises That A Condition of Its Offer for Afexa Life Sciences CannotBe Fulfilled |
| September 30, 2011 |
AMENDMENT TO THE ACQUISITION SUPPORT AGREEMENT |
| September 30, 2011 |
News Release – VALEANT ANNOUNCES THAT AFEXA SUPPORTS AND RECOMMENDS VALEANT’S INCREASED OFFER AND AGREES TO CERTAIN AMENDMENTS TO SUPPORT AGREEMENT
- Valeant’s increased offer is C$0.85 per Afexa common share
- Offer no longer subject to a minimum tender condition, comparable to Paladin's no minimum tender condition, providing greater certainty of completion
- Break up fee increased from C$3.75 million to C$4.5 million, which is proportional to the increase in aggregate purchase price under Valeant's offer
|
| September 30, 2011 |
News Release: Afexa Provides Recommendation That Shareholders Accept the Increased Valeant Offer |
| September 28, 2011 |
News Release: Afexa provides update on takeover offers and ASC decision on Shareholder Rights Plans |
| September 26, 2011 |
News Release: Paladin Labs Confirms Enhanced $0.81 per Share Offer to Acquire Afexa Life Sciences |
| September 26, 2011 |
ASC Order Cease Trading the Shareholder Rights Plan Effective September 30, 2011 |
| September 26, 2011 |
News Release – VALEANT PHARMACEUTICALS INTENDS TO RAISE OFFER FOR AFEXA LIFE SCIENCES INC. TO $0.85 PER SHARE
- Increased offer subject to Afexa’s agreement to certain amendments to support agreement
- Represents a premium over Paladin Labs’ most recent offer
|
| September 25, 2011 |
Paladin Labs Announces Proposed Increased Offer to Acquire Afexa Life Sciences for $0.81 per Share
Increased offer will be made upon cease-trade of Afexa Rights Plans - 14% premium to the Valeant bid - Choice of $0.81 in cash or 0.0217 of a Paladin share per Afexa share - Offer remains for any and all Afexa shares - Minimal and customary conditions |
| September 22, 2011 |
News Release: Afexa’s response to Paladin’s announced intention to enhance its takeover offer for Afexa |
| September 22, 2011 |
News Release: Paladin Announces Intention to Enhance Offer for Afexa “in the event that Afexa’s two shareholder rights plans are waived by Afexa or cease-traded by the ASC” |
| September 15, 2011 |
Paladin extends expiry of its takeover offerof Afexa until 8:00 p.m. ET on September 28, 2011 |
| September 9, 2011 |
Valeant News Release regarding takeover bid |
| September 9, 2011 |
News Release: Afexa mails circular in support of Valeant Offer and Appoints Interim CEO for transition |
| September 9, 2011 |
Afexa mails Directors’ Circular recommending acceptance of Valeants’ offer |
| September 9, 2011 |
Cover letter mailed with Directors’ circular |
| September 9, 2011 |
Valeant mails takeover bid circular to Afexa shareholders |
| September 9, 2011 |
Cover letter from Valeant mailed with Directors’ Circular |
| August 30, 2011 |
News Release: Afexa agrees to support an offer by Valeant Pharmaceuticals; definitive acquisition support agreement |
| August 30, 2011 |
Valeant announces all-cash offer to acquire Afexa |
| August 30, 2011 |
Acquisition Support Agreement filed on SEDAR |
| August 23, 2011 |
News Release: Afexa’s Board unanimously confirms previous recommendation that shareholders reject Paladin’s unsolicited offer. “Take No Action” |
| August 22, 2011 |
Afexa mails Directors’ Circular recommending Rejection of Paladin Offer (mailed Aug 25) |
| August 22, 2011 |
Cover letter for Directors’ Circular (Mailed Aug 25) |
| August 19, 2011 |
Chairman’s letter to shareholders; “Paladin offer significantly undervalues Afexa’s business” |
| August 10, 2011 |
Paladin Offer to Purchase Circular Mailed to Afexa Shareholders |
| August 10, 2011 |
News Release: Afexa Responds to Unsolicited Bid; significantly undervalues Afexa’s business. Special Committee of the Board formed to review the offer. Shareholders urged to not take any action until the Board has completed its full review and consideration of the Offer. |
| August 10, 2011 |
Paladin News Release announcing hostile takeover bid of Afexa; offering shareholders $0.55 per common share |
| July 18, 2011 |
News Release: Afexa comments on Paladin announcement that it has purchased 14.94% of Afexa’s total issued and outstanding common shares for a total ownership representing 15,421,300 common shares |
| July 15, 2011 |
Paladin announces purchase of Afexa shares; 14.94% of total issued and outstanding shares |
